# RIN3

## Overview
RIN3 is a gene that encodes the protein Ras and Rab interactor 3, which functions as a guanine nucleotide exchange factor (GEF) primarily for the Rab5 subfamily of small GTPases. This protein is integral to intracellular signaling and endocytosis, facilitating the exchange of GDP for GTP on Rab proteins, thereby activating them and promoting vesicle trafficking within cells (Kajiho2011Characterization; Shen2022Ras). RIN3 is characterized by several functional domains, including a Src homology 2 (SH2) domain, a proline-rich domain (PRD), and a VPS9 domain, which are essential for its interactions and GEF activity (Kajiho2011Characterization; Shen2022Ras). The protein is involved in various cellular processes, including endosomal trafficking and bone metabolism, and has been implicated in diseases such as Alzheimer's Disease and Paget's Disease of Bone due to its role in endocytic processes and intracellular signaling (Vallet2021Targeted; Meshref2023The).

## Structure
The RIN3 protein is characterized by several functional domains that contribute to its role in intracellular signaling and endocytosis. It contains a Src homology 2 (SH2) domain, which interacts with tyrosine-phosphorylated receptors and modulates guanine nucleotide exchange factor (GEF) activity (Shen2022Ras; Meshref2023The). The protein also features a proline-rich domain (PRD), which facilitates interactions with proteins like CD2AP and BIN1/BIN2 through their SH3 domains (Shen2022Ras; Rouka2015Differential). The RIN-homology (RH) domain is crucial for interaction with Rab5, providing substrate specificity (Shen2022Ras).

The VPS9 domain is essential for RIN3's GEF activity, catalyzing the release of GDP from Rab proteins, particularly Rab5, Rab21, and Rab31 (Kajiho2011Characterization; Shen2022Ras). The Ras-association (RA) domain, present in all RIN proteins, is associated with Ras interaction, although its specific role in RIN3 remains unexplored (Shen2022Ras).

RIN3 is known to have splice variant isoforms, which may affect its function and interactions. Post-translational modifications, such as phosphorylation, can regulate its activity. The protein's molecular structure has been partially predicted using AlphaFold, but the complete 3D structure is not yet resolved (Shen2022Ras).

## Function
RIN3 (Ras and Rab interactor 3) functions as a guanine nucleotide exchange factor (GEF) primarily for the Rab5 subfamily of small GTPases, particularly Rab31. This protein plays a crucial role in regulating endocytosis and vesicle trafficking within cells. RIN3 facilitates the exchange of GDP for GTP on Rab31, thereby activating it and promoting its involvement in intracellular membrane trafficking processes, such as the transport between the trans-Golgi network and early endosomes (Kajiho2011Characterization).

The VPS9 domain of RIN3 is essential for its GEF activity, catalyzing the release of GDP from Rab proteins and promoting GTP binding, which is necessary for its role in endocytosis and cellular signaling (Shen2022Ras). RIN3's activity influences the morphology of Rab31-positive structures, inducing the enlargement of endosomes and tubulovesicular structures, which is dependent on its GEF activity (Kajiho2011Characterization).

RIN3 is also involved in bone metabolism, where it negatively regulates trabecular bone mass by inhibiting osteoclastic bone resorption and promoting bone formation (Vallet2021Targeted). Additionally, RIN3 interacts with CD2-associated protein (CD2AP), playing a role in endosomal trafficking and potentially linking to conditions such as late-onset Alzheimer's disease (Rouka2015Differential).

## Clinical Significance
The RIN3 gene is implicated in several diseases due to mutations and alterations in its expression. In Alzheimer's Disease (AD), RIN3 is considered a risk factor for both late-onset and early-onset forms. Upregulation of RIN3 in AD is associated with endosomal dysfunction, increased amyloid-beta accumulation, and tau phosphorylation, contributing to the disease's pathogenesis (Meshref2023The; Shen2020Upregulation). A specific single nucleotide polymorphism (SNP) upstream of the RIN3 coding sequences is linked to increased expression in AD, and hypomethylation of RIN3 is observed in AD patients, suggesting a role in disease progression (Shen2022Ras; Meshref2023The).

RIN3 is also involved in Paget's Disease of Bone (PDB), where genetic variations at the 14q32 locus, including the rs117068593 variant, are associated with the disease. These variations may affect osteoclast function and bone resorption, contributing to PDB pathogenesis (De2019Genetic; Shen2022Ras). The gene's role in intracellular trafficking and endocytosis is crucial in these conditions, highlighting its clinical significance in both neurodegenerative and bone disorders (Shen2022Ras).

## Interactions
RIN3 (Ras and Rab interactor 3) is involved in several protein interactions, primarily through its proline-rich domains (PRDs) and SH2 domain. It interacts with the CD2-associated protein (CD2AP) via its SH3 domains, with RIN3 binding strongly to SH3-1, weakly to SH3-2, and not at all to SH3-3. This interaction is facilitated by specific motifs within RIN3, identified as RIN3e1 and RIN3e2, which are crucial for binding to CD2AP and recruiting it to RAB5a-positive endosomes (Rouka2015Differential).

RIN3 also interacts with bridging integrator 1 (BIN1), forming a complex that is implicated in Alzheimer's disease pathogenesis. This complex, which includes CD2AP, is involved in endocytic trafficking and amyloidogenic processing of APP, as well as tau phosphorylation (Shen2022Ras; Shen2020Upregulation).

RIN3 functions as a guanine nucleotide exchange factor (GEF) for Rab31 and Rab5, facilitating the formation of GTP-bound states of these GTPases. This activity is crucial for its role in vesicle trafficking and is mediated by its VPS9 domain (Kajiho2011Characterization). RIN3's interactions with these proteins highlight its role in intracellular signaling and endocytic processes.


## References


[1. (Shen2022Ras) Ruinan Shen, Caitlin J Murphy, Xiaowen Xu, Mingzheng Hu, Jianqing Ding, and Chengbiao Wu. Ras and rab interactor 3: from cellular mechanisms to human diseases. Frontiers in Cell and Developmental Biology, March 2022. URL: http://dx.doi.org/10.3389/fcell.2022.824961, doi:10.3389/fcell.2022.824961. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.824961)

[2. (Kajiho2011Characterization) Hiroaki Kajiho, Kyoko Sakurai, Tomohiro Minoda, Manabu Yoshikawa, Satoshi Nakagawa, Shinichi Fukushima, Kenji Kontani, and Toshiaki Katada. Characterization of rin3 as a guanine nucleotide exchange factor for the rab5 subfamily gtpase rab31. Journal of Biological Chemistry, 286(27):24364–24373, July 2011. URL: http://dx.doi.org/10.1074/jbc.M110.172445, doi:10.1074/jbc.m110.172445. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.172445)

[3. (Meshref2023The) Mostafa Meshref, Hazem S. Ghaith, Mohamed Ahmed Hammad, Mahmoud Mohamed Mohamed Shalaby, Faris Ayasra, Fatma Ahmed Monib, Mohamed S. Attia, Mahmoud A. Ebada, Hanaa Elsayed, Ali Shalash, and Eshak I. Bahbah. The role of rin3 gene in alzheimer’s disease pathogenesis: a comprehensive review. Molecular Neurobiology, 61(6):3528–3544, November 2023. URL: http://dx.doi.org/10.1007/s12035-023-03802-0, doi:10.1007/s12035-023-03802-0. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-023-03802-0)

[4. (Shen2020Upregulation) Ruinan Shen, Xiaobei Zhao, Lu He, Yongbo Ding, Wei Xu, Suzhen Lin, Savannah Fang, Wanlin Yang, Kijung Sung, Brian Spencer, Robert A. Rissman, Ming Lei, Jianqing Ding, and Chengbiao Wu. Upregulation of rin3 induces endosomal dysfunction in alzheimer’s disease. Translational Neurodegeneration, June 2020. URL: http://dx.doi.org/10.1186/s40035-020-00206-1, doi:10.1186/s40035-020-00206-1. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s40035-020-00206-1)

[5. (Vallet2021Targeted) Mahéva Vallet, Antonia Sophocleous, Anna E. Törnqvist, Asim Azfer, Rob van’t Hof, Omar ME Albagha, and Stuart H. Ralston. Targeted inactivation of rin3 increases trabecular bone mass by reducing bone resorption and favouring bone formation. Calcified Tissue International, 109(1):92–102, March 2021. URL: http://dx.doi.org/10.1007/s00223-021-00827-2, doi:10.1007/s00223-021-00827-2. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00223-021-00827-2)

[6. (De2019Genetic) Raphaël De Ridder, Eveline Boudin, Geert Vandeweyer, Jean-Pierre Devogelaer, Erik Fransen, Geert Mortier, and Wim Van Hul. Genetic variation in rin3 in the belgian population supports its involvement in the pathogenesis of paget’s disease of bone and modifies the age of onset. Calcified Tissue International, 104(6):613–621, February 2019. URL: http://dx.doi.org/10.1007/s00223-019-00530-3, doi:10.1007/s00223-019-00530-3. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00223-019-00530-3)

[7. (Rouka2015Differential) Evgenia Rouka, Philip C. Simister, Melanie Janning, Joerg Kumbrink, Tassos Konstantinou, João R.C. Muniz, Dhira Joshi, Nicola O’Reilly, Rudolf Volkmer, Brigitte Ritter, Stefan Knapp, Frank von Delft, Kathrin H. Kirsch, and Stephan M. Feller. Differential recognition preferences of the three src homology 3 (sh3) domains from the adaptor cd2-associated protein (cd2ap) and direct association with ras and rab interactor 3 (rin3). Journal of Biological Chemistry, 290(42):25275–25292, October 2015. URL: http://dx.doi.org/10.1074/jbc.m115.637207, doi:10.1074/jbc.m115.637207. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m115.637207)